EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted MRM Quantification of Urinary Proteins in Chronic Kidney Disease Caused by Glomerulopathies

Alexey S Kononikhin, Alexander G Brzhozovskiy, Anna E Bugrova iD, Natalia V Chebotareva iD, Natalia V Zakharova, Savva Semenov iD, Anatoliy Vinogradov, Maria I Indeykina iD, Sergey Moiseev, Irina M Larina, Evgeny N Nikolaev iD

Molecules · 2023

DOI: 10.3390/molecules28083323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Alexey S Kononikhin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Bolshoy Boulevard 30, Bld. 1, 121205 Moscow, Russia. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Kidney Failure, Chronic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glomerulopathies with nephrotic syndrome that are resistant to therapy often progress to end-stage chronic kidney disease (CKD) and require timely and accurate diagnosis. Targeted quantitative urine proteome analysis by mass spectrometry (MS) with multiple-reaction monitoring (MRM) is a promising tool for early CKD diagnostics that could replace the invasive biopsy procedure. However, there are few studies regarding the development of highly multiplexed MRM assays for urine proteome analysis, and the two MRM assays for urine proteomics described so far demonstrate very low consistency. Thus, the further development of targeted urine proteome assays for CKD is actual task. Herein, a BAK270 MRM assay previously validated for blood plasma protein analysis was adapted for urine-targeted proteomics. Because proteinuria associated with renal impairment is usually associated with an increased diversity of plasma proteins being present in urine, the use of this panel was appropriate. Another advantage of the BAK270 MRM assay is that it includes 35 potential CKD markers described previously. Targeted LC-MRM MS analysis was performed for 69 urine samples from 46 CKD patients and 23 healthy controls, revealing 138 proteins that were found in ≥2/3 of the samples from at least one of the groups. The results obtained confirm 31 previously proposed CKD markers. Combination of MRM analysis with machine learning for data processing was performed. As a result, a highly accurate classifier was developed (AUC = 0.99) that enables distinguishing between mild and severe glomerulopathies based on the assessment of only three urine proteins (GPX3, PLMN, and A1AT or SHBG).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicKidney Failure, ChronicHumansProteomeMass SpectrometryProteinuriaBlood ProteinsBiomarkers

Stichwörter der Autor:innen

chronic kidney diseasemass spectrometrymultiple-reaction monitoringproteomicsurine proteomics

Substanzen

ProteomeBlood ProteinsBiomarkers

Autor:innen und Institutionen

  • Center for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Bolshoy Boulevard 30, Bld. 1, 121205 Moscow, Russia.
  • Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health, 117997 Moscow, Russia.
  • Emanuel Institute for Biochemical Physics, Russian Academy of Science, Kosygina Str. 4, 119334 Moscow, Russia.
  • Nephrology Department, Sechenov First Moscow State Medical University, Trubezkaya 8, 119048 Moscow, Russia.
  • Department of Internal Medicine, Lomonosov Moscow State University, GSP-1, Leninskie Gory, 119991 Moscow, Russia.
  • Moscow Institute of Physics and Technology, 141700 Dolgoprudny, Russia.

ORCID-Profile: Anna E Bugrova, Natalia V Chebotareva, Savva Semenov, Maria I Indeykina, Evgeny N Nikolaev

Förderung

  • Russian Science Foundation

Zitieren

APA

Kononikhin, A. S., Brzhozovskiy, A. G., Bugrova, A. E., Chebotareva, N. V., Zakharova, N. V., Semenov, S., Vinogradov, A., Indeykina, M. I., Moiseev, S., Larina, I. M., & Nikolaev, E. N. (2023). Targeted MRM Quantification of Urinary Proteins in Chronic Kidney Disease Caused by Glomerulopathies. Molecules. https://doi.org/10.3390/molecules28083323

Vancouver

Kononikhin AS, Brzhozovskiy AG, Bugrova AE, Chebotareva NV, Zakharova NV, Semenov S, et al. Targeted MRM Quantification of Urinary Proteins in Chronic Kidney Disease Caused by Glomerulopathies. Molecules. 2023. doi:10.3390/molecules28083323

BibTeX
@article{Kononikhin2023,
  author = {Kononikhin, Alexey S and Brzhozovskiy, Alexander G and Bugrova, Anna E and Chebotareva, Natalia V and Zakharova, Natalia V and Semenov, Savva and Vinogradov, Anatoliy and Indeykina, Maria I and Moiseev, Sergey and Larina, Irina M and Nikolaev, Evgeny N},
  title = {Targeted MRM Quantification of Urinary Proteins in Chronic Kidney Disease Caused by Glomerulopathies},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28083323}
}
Kostenlos starten →